Alvotech and Sandoz strike major biosimilar deals for Canada and Oceania
Alvotech (NASDAQ:ALVO) solidified its global commercialization strategy on Monday, entering into new supply and marketing agreements with Sandoz to bring a suite of biosimilar candidates to Canada, Australia, and New Zealand.





-640x360.jpg&w=1200&q=75)
-640x360.jpg&w=1200&q=75)




-640x400.jpg&w=1200&q=75)









